// App-Quantinova.ai

: Brain structural alterations in cognitively unimpaired individuals with discordant amyloid-β PET and CSF Aβ42 status: findings using Machine Learning

Researchers

Presenter

  • Irene Cumplido-Mayoral

Principal Investigators

  • Mahnaz Shekari

  • Gemma Salvadó

  • Greg Operto

  • Raffaele Cacciaglia

  • Carles Falcon

  • Aida Niñerola-Baizán

  • Andrés Perissinotti

  • Carolina Minguillón

  • Karine Fauria

  • Ivonne Suridjan

  • Gwendlyn Kollmorgen

  • Jose Molinuevo

  • Henrik Zetterberg

  • Kaj Blennow

  • Marc Suárez-Calvet

  • Verónica Vilaplana

  • Juan Domingo Gispert

Medical Centers

  • Laboratory of Neuroimaging (LONI), University of Southern California

  • Hospital del Mar Medical Research Insitute (IMIM)

  • Hospital del Mar Medical Research Insitute (IMIM)

  • Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN)

  • Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation

  • *Current Address: H. Lundbeck A/S

  • Department of Signal Theory and Communications, Universitat Politècnica de Catalunya

  • Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London

  • Servei de Neurologia, Hospital del Mar

  • Nuclear Medicine Department, Hospital Clinic, Barcelona, Spain

  • Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES)

  • Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation

  • Universitat Pompeu Fabra,

  • Roche Diagnostics International AG

  • UK Dementia Research Institute

  • Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Sweden

  • Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden

  • Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Moelndal, Sweden

Locations

  • India

  • Venezuela

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Amyloid beta 42

  • Cerebrospinal fluid

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved